A new challenge for control selection in influenza vaccine effectiveness test-negative design studies in the COVID-19 context:Results from European I- MOVE multicentre study at primary care level (CROSBI ID 728417)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Kissling, Esther ; Martinez-Baz, Ivan, Buda, Silke, Mazgatos, Clara ; Višekruna Vučina, Vesna ; Nonković, Diana ; et al.
I-MOVE-COVID-19 and ECDC primary care study team
engleski
A new challenge for control selection in influenza vaccine effectiveness test-negative design studies in the COVID-19 context:Results from European I- MOVE multicentre study at primary care level
31% of controls were positive for SARS-CoV-2, exluding them increased IVE estimation by <10% overall. and only 3% in the vaccination target group.
COVID-19 ; vaccination ; influenza ; case-control studies ; multicentre study
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
54-55.
2022.
objavljeno
Podaci o matičnoj publikaciji
Abstract book: ESCAIDE 2022 European Scientific Conference on Applied Infectious Epidemiology
Catchpole, Mike
Stockholm: ECDC
978-953-7124-12-0
Podaci o skupu
European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE 2022)
predavanje
23.11.2022-25.11.2022
Stockholm, Švedska
